PYOTT DAVID E I

Director at ALLERGAN INC · on record since Feb 8, 2006
Director at Avery Dennison Corp · on record since Jun 30, 2006
Director at Edwards Lifesciences Corp · on record since May 15, 2006
Director at ALNYLAM PHARMACEUTICALS, INC. · on record since May 22, 2026
Chairman, President and CEO at ALLERGAN INC · on record since Oct 28, 2003
Director at Tarsus Pharmaceuticals, Inc. · on record since Apr 28, 2026
Director at BIOMARIN PHARMACEUTICAL INC · on record since Jan 6, 2016
Director at PLIANT THERAPEUTICS, INC. · on record since Jan 13, 2021

Insider trading activity of PYOTT DAVID E I

Transactions on record: 497; since Sep 30, 2003

Open-market buys: 5; $3.2M

Open-market sells: 125; $299.6M

Companies traded: 7; last filing Sep 17, 2026

Figures computed from official regulatory filings — .

Companies where PYOTT DAVID E I has traded

Tarsus Pharmaceuticals, Inc.9 tx · Sep 17, 2026
ALNYLAM PHARMACEUTICALS, INC.37 tx · $14.8M · Jun 3, 2026
PLIANT THERAPEUTICS, INC.7 tx · Jun 9, 2025
BIOMARIN PHARMACEUTICAL INC15 tx · $1M · May 23, 2024
Avery Dennison Corp136 tx · $3.3M · Apr 24, 2020
ALLERGAN INC244 tx · $571.9M · Mar 19, 2015
Edwards Lifesciences Corp49 tx · $8.8M · May 13, 2014

Track record of PYOTT DAVID E I

Statistical track record

Free account

Open-market buys: 5

Last buy: Aug 31, 2020

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of PYOTT DAVID E I

Co-insiders of PYOTT DAVID E I

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Tarsus Pharmaceuticals, Inc.Listing on record	Sep 17, 2026	Exercise	201	—	n/a (No price was disclosed in the filing)	SEC
Tarsus Pharmaceuticals, Inc.Listing on record	Sep 17, 2026	ExerciseD (derivative)	-201	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Tarsus Pharmaceuticals, Inc.Listing on record	Jun 29, 2026	AwardD (derivative)	2,417	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Tarsus Pharmaceuticals, Inc.Listing on record	Jun 29, 2026	AwardD (derivative)	3,837	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Tarsus Pharmaceuticals, Inc.Listing on record	Jun 29, 2026	AwardD (derivative)	806	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	Jun 3, 2026	ExerciseD (derivative)	-3,830	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	Jun 3, 2026	Sell	-495	300.72 USD	$148.9K	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	Jun 3, 2026	Sell	-1,175	298.91 USD	$351.2K	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	Jun 3, 2026	Sell	-17	302.65 USD	$5.1K	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	Jun 3, 2026	Sell	-1,222	299.87 USD	$366.4K	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	Jun 3, 2026	Exercise	3,830	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	Jun 3, 2026	Sell	-921	297.71 USD	$274.2K	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	May 22, 2026	AwardD (derivative)	1,441	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	May 22, 2026	Award	671	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Tarsus Pharmaceuticals, Inc.Listing on record	Apr 28, 2026	Exercise	1,383	—	n/a (No price was disclosed in the filing)	SEC
Tarsus Pharmaceuticals, Inc.Listing on record	Apr 28, 2026	ExerciseD (derivative)	-1,383	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Tarsus Pharmaceuticals, Inc.Listing on record	Feb 20, 2026	AwardD (derivative)	3,729	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Tarsus Pharmaceuticals, Inc.Listing on record	Feb 20, 2026	AwardD (derivative)	5,893	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
PLIANT THERAPEUTICS, INC.Listing on record	Jun 9, 2025	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	May 12, 2025	Award	775	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	May 12, 2025	AwardD (derivative)	1,558	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	Mar 25, 2025	Exercise	7,440	88.95 USD	$661.8K	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	Mar 25, 2025	ExerciseD (derivative)	-7,440	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	Mar 25, 2025	Sell	-7,440	299.00 USD	$2.2M	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	Jun 26, 2024	Sell	-7,420	221.00 USD	$1.6M	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Tarsus Pharmaceuticals, Inc.Listing on record	Sep 17, 2026	Exercise	201	—	n/a (No price was disclosed in the filing)	SEC
Tarsus Pharmaceuticals, Inc.Listing on record	Sep 17, 2026	ExerciseD (derivative)	-201	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Tarsus Pharmaceuticals, Inc.Listing on record	Jun 29, 2026	AwardD (derivative)	2,417	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Tarsus Pharmaceuticals, Inc.Listing on record	Jun 29, 2026	AwardD (derivative)	3,837	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Tarsus Pharmaceuticals, Inc.Listing on record	Jun 29, 2026	AwardD (derivative)	806	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	Jun 3, 2026	ExerciseD (derivative)	-3,830	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	Jun 3, 2026	Sell	-495	300.72 USD	$148.9K	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	Jun 3, 2026	Sell	-1,175	298.91 USD	$351.2K	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	Jun 3, 2026	Sell	-17	302.65 USD	$5.1K	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	Jun 3, 2026	Sell	-1,222	299.87 USD	$366.4K	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	Jun 3, 2026	Exercise	3,830	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	Jun 3, 2026	Sell	-921	297.71 USD	$274.2K	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	May 22, 2026	AwardD (derivative)	1,441	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	May 22, 2026	Award	671	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Tarsus Pharmaceuticals, Inc.Listing on record	Apr 28, 2026	Exercise	1,383	—	n/a (No price was disclosed in the filing)	SEC
Tarsus Pharmaceuticals, Inc.Listing on record	Apr 28, 2026	ExerciseD (derivative)	-1,383	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Tarsus Pharmaceuticals, Inc.Listing on record	Feb 20, 2026	AwardD (derivative)	3,729	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Tarsus Pharmaceuticals, Inc.Listing on record	Feb 20, 2026	AwardD (derivative)	5,893	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
PLIANT THERAPEUTICS, INC.Listing on record	Jun 9, 2025	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	May 12, 2025	Award	775	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	May 12, 2025	AwardD (derivative)	1,558	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	Mar 25, 2025	Exercise	7,440	88.95 USD	$661.8K	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	Mar 25, 2025	ExerciseD (derivative)	-7,440	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	Mar 25, 2025	Sell	-7,440	299.00 USD	$2.2M	SEC
ALNYLAM PHARMACEUTICALS, INC.Listing on record	Jun 26, 2024	Sell	-7,420	221.00 USD	$1.6M	SEC